D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 46.88 CNY -1.62% Market Closed
Market Cap: 19.5B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Net Margin
Dizal Jiangsu Pharmaceutical Co Ltd

-632.9%
Current
-4 541%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-632.9%
=
Net Income
-1.1B
/
Revenue
172.6m

Net Margin Across Competitors

Country CN
Market Cap 19.1B CNY
Net Margin
-633%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 352.5B USD
Net Margin
9%
Country US
Market Cap 174.8B USD
Net Margin
13%
Country US
Market Cap 133.2B USD
Net Margin
-5%
Country US
Market Cap 120.3B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 137.9B AUD
Net Margin
18%
Country US
Market Cap 91.2B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 33.2B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Dizal Jiangsu Pharmaceutical Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-632.9%
=
Net Income
-1.1B
/
Revenue
172.6m
What is the Net Margin of Dizal Jiangsu Pharmaceutical Co Ltd?

Based on Dizal Jiangsu Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of -632.9%.